American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

February 09, 2022

Newsletter Sponsor

Application Note - Forced Degradation Data Management in Drug Development

Forced degradation studies are a critical element of the drug development process. This highly collaborative work involves massive amounts of data spread across multiple electronic systems. Consolidating this experimental data is time-consuming, tedious, and error-prone.

This application note explains how a CMC decision support tool can simplify data management and track task completion. Learn how to increase your team’s efficiency and improve collaboration during forced degradation research. Read the application note.

	Industry News

U.S. Govt Receives 3.1 Million Courses of Molnupiravir for Use in the United States
Merck and Ridgeback Biotherapeutics announced that a total of approximately 3.1 million courses of ... read more »

Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims
Teva Pharmaceuticals has reached an agreement with the Attorney General (AG) of Texas that settles ... read more »

mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer ... read more »

Seqirus Announces New Facility Supporting R&D of Leading-Edge Influenza Vaccine Technology
Seqirus, a business of CSL Limited, announced an investment in a new Research and Development (R&D) ... read more »

	Infographic

Tableting with Coprocessed Excipients
Tableting with Coprocessed Excipients
Explore this infographic that outlines the most important benefits of coprocessed excipients for your tableting process. read more »

	Featured Articles

Leveraging Direct Compression Technology to Improve Tableting Efficiency One of the most common pharmaceutical dosage forms in drug delivery is the tablet; they’re a favorable dosage form for several reasons: dosing ... read more »

Microbial Control Strategy for iNeST mRNA a Cell-Free, Individualized ATMP Advanced therapy medicinal products (ATMPs) also referred to as Cell and Gene Therapy products (CGT) are a new class of drugs which is fundamentally ... read more »

	Featured Video

On-Demand Webinar: Viral Control in Pharmaceutical Processing
This webinar discusses the essential elements of control, testing, and remediation and it includes a spotlight on the maim viruses of concern. watch »

On-Demand Webinar: Disinfectant Efficacy Testing – Coupon/Carrier Method
We aim to provide insight into how the results of a coupon study can be utilized to improve cleaning procedures. watch »

	Featured Products

PURELAB® Chorus 1 Complete Ultrapure Water System
read more »

	Featured Whitepaper

Whitepaper: Global regulators’ FAQs on CMC in IND/BLA filing
Mammalian cell cultures used in the manufacturing of therapeutics must be tested to ensure lack of mycoplasmal contamination. Previously, the only test for mycoplasma accepted by regulatory agencies ... read more »

	Events

SmartLab Exchange
Virtual – 02/16/2022
The Smartlab Exchange brings together some of the leading minds responsible spearheading innovative laboratory strategies across the R&D/R&D IT, ... event details »

IFPAC
North Bethesda, Maryland – 02/27/2022
IFPAC brings together experienced professionals and the next generation of leaders to share in discussions, give input and get ideas for the future ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA